Jeuveau®

Jeuveau®, often referred to as "Newtox," is an FDA-approved injectable treatment designed to reduce the appearance of fine lines and wrinkles, particularly in the facial area. Manufactured by Evolus, Jeuveau® is a botulinum toxin type A product, similar to other popular neurotoxins like Botox® and Dysport®. Specifically formulated for aesthetic purposes, Jeuveau® is primarily used to smooth dynamic wrinkles, such as frown lines (glabellar lines) that form due to repeated facial expressions over time.

Jeuveau’s cutting-edge formulation and competitive pricing have made it a sought-after choice for individuals looking to achieve a refreshed, youthful appearance without surgery. Since its approval in 2019, Jeuveau® has become a favorite among patients and practitioners for its effectiveness and targeted results.

Jeuveau® works by temporarily relaxing the muscles responsible for dynamic wrinkles. The active ingredient, botulinum toxin type A, blocks nerve signals to the treated muscles, preventing them from contracting. When the muscles are unable to contract, the overlying skin smooths out, reducing the appearance of wrinkles and fine lines. Patients may begin to notice results within 2 to 3 days after treatment, with full effects visible around 7 to 10 days. To maintain optimal results, many patients schedule follow-up treatments every 3 to 4 months. Regular maintenance can help ensure consistent wrinkle reduction and prevent the reappearance of deeper lines. The effects of Jeuveau® generally last between 3 to 5 months. Jeuveau® is an excellent option for adults looking to reduce the appearance of dynamic wrinkles, particularly frown lines between the eyebrows. However, it’s important to consult with a qualified provider to determine if Jeuveau® is the right choice for your needs and goals.